Table 1.
Drug | Dose | Special Considerations |
---|---|---|
UFH 1 | 80 unit/kg IV bolus, followed by an 18-unit/kg/hour infusion [6]. | |
Enoxaparin | 1 mg/kg subQ 2 BID 3 [12,13]. | |
Dalteparin | 200 IU/kg/day 4 subQ for one month, followed by 150 IU/kg/day subcutaneously for months 2 through 6 [14]. | Maximum of 18,000 IU per day. |
Fondaparinux | <50 kg: 5 mg subQ daily 50–100 mg: 7.5 mg subQ daily >100 kg: 10 mg subQ daily |
Initiate warfarin within 72 h and give concomitantly for at least 5 days. |
Edoxaban | 60 mg po once daily; 30 mg once daily if body weight ≤60 kg | Not for use in patients with CrCl > 95 mL/min 5. Dose after 5 to 10 days of initial therapy with a parenteral anticoagulant. |
Apixaban | 10 mg po twice daily for 7 days followed by 5 mg twice daily [15]. | |
Rivaroxaban | 15 mg po twice daily × 3 weeks, then 20 mg once daily × at least 6 months [16]. | Take with food to improve absorption [17,18,19] |
Dabigatran | 150 mg po BID [20].; 110 mg BID for patients ≥80 years | Dose after 5 to 10 days of initial therapy with a parenteral anticoagulant. Reduce dose to 110 mg BID for patients ≥80 years or ≥75 years with at least one bleeding risk factor. |
1 UFH: unfractionated heparin; 2 subQ: subcutaneously; 3 BID: twice a day; 4 IU: international units; 5 CrCL: creatinine clearance.